HighLife
HighLife Medical develops a transcatheter mitral-valve replacement system designed to treat patients with severe mitral regurgitation without open-heart surgery.
€80MFinancing round
ParticipantEI
European Investment Bank
Activity from announced rounds
Activity in this selectionFrance · Oct 12, 2026 · Jul 15, 2026
The European Investment Bank, abbreviated EIB, is the bank named in Reactive Technologies and Tensive financing announcements.
Recorded funding activity
Reactive measures electricity-grid inertia and stability in real time. Other recorded activity includes Morphotonics’ optical-component manufacturing equipment and HighLife’s transcatheter heart-valve technology. The bank remains distinct from the European Investment Fund and other institutions.
- Rounds participated in
- 1
- Confirmed lead rounds
- 0 All roles disclosed
- New companies
- 1 First participation on record · 0 follow-on
- Funding in participating rounds
- $91.7M 1 disclosed · full round size, not this investor’s share